Frontlight ResearchEarly access
Chronic kidney disease trials in Italy
27 of 43 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ItalyImlifidase Prior to Kidney Transplant in Highly Sensitised Children
- Where
- Rome
- Age
- 1 year to 17 years
- People
- 10 worldwide
- Run by
- Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Bassano Del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara, Padova, Pavia, Pisa, Pordenone, Rome, Rozzano, Tradate VA, Turin
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Bologna, Brescia, Ferrara, Florence, Genoa, Milan, Monza, Palermo, Parma, Perugia, Rome, Rozzano, San Donato Milanese
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 4Taking peopleCKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease
- Where
- Bologna, Naples
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Steno Diabetes Center Copenhagen
See details and how to join2023-507449-27-01 - Phase 3Active, not recruitingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Bologna, Naples
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 3Active, not recruitingA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Bologna, Florence, Genoa, Milan, Rome, Turin
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3Not yet taking people in ItalyA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples, Palermo, Pavia, Ranica, Verona
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Bologna, Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia, Genova, Lecce, Lecco, Messina, Milan, Naples, Novara, Pavia, Peschiera del Garda, Piacenza, Pisana, Prato, Reggio Calabria, Rimini, Roma, Rome, San Giovanni Rotondo, Verona
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseNot yet taking people in ItalyDialysisBot: AI Chatbot for Hemodialysis Self-Management
- Where
- Molfetta
- Age
- 18 years and over
- People
- 40
- Run by
- University of Rome Tor Vergata
See details and how to joinNCT07830810 - Phase 3Taking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Brescia, Florence, Foggia, Genoa, Milan, Pavia, Pisa, Verona
- Age
- 18 years and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 - No phaseTaking peoplePhysical Exercise in Patients With Chronic Kidney Disease in Hemodialysis (Pehedal-ESKD)
- Where
- Torre del Greco
- Age
- 18 years and over
- People
- 312
- Run by
- Ricerca Nefrocenter
See details and how to joinNCT07820514 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Alexandria, Bari, Bologna, Catania, Chieri, Como, Cosenza, Feltre, Foggia, Naples, Pavia, Pordenone, Ranica, Rome, Salerno, San Giovanni Rotondo, Sesto San Giovanni, Trieste
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - Phase 3CompletedA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Florence
- Age
- 2 years to 17 years
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - Phase 3Taking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
- Age
- 18 years and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785 - Phase 3Taking peopleEfficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Where
- Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan, Modena, Naples, Padova, Piacenza, Roma, San Benedetto del Tronto, Terni, Torino, Verona
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Iperboreal Pharma Srl
See details and how to joinNCT03994471 - Phase 2CompletedA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Bergamo, Bologna, Brescia, Chieti Scalo, L'aquila, Milan, Pisa, Rome
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleAnalysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment
- Where
- Peschiera del Garda
- Age
- 18 years and over
- People
- 50
- Run by
- Casa di Cura Dott. Pederzoli
See details and how to joinNCT07438002 - Phase 2WithdrawnSafety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
- Where
- Roma
- People
- 28 worldwide
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
See details and how to joinNCT04580420 - No phaseNot yet taking people in ItalyMechanisms Underlying SGLT2i Kidney Effect in DKD Progression
- Where
- Ranica
- Age
- 18 years and over
- People
- 100
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT07270198 - No phaseNot yet taking people in ItalyPhysical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
- Where
- Ariano Irpino
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Biogem s.c.ar.l.
See details and how to joinNCT07160959 - No phaseTaking peopleBlood Flow Conditions and Sounds in AVFs
- Where
- Bergamo
- Age
- 18 years to 90 years
- People
- 15
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT06411353 - Phase 3Taking peoplePatiromer and Diet/hrQoL in Chronic Dialysis
- Where
- Bergamo, Busto Arsizio, Cinisello Balsamo, Saronno, Sesto San Giovanni
- Age
- 18 years and over
- People
- 40
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT06858280 · EU 2025-521378-33-00 - No phaseNot yet taking people in ItalyFirst-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
- Where
- Modena
- Age
- 18 years and over
- People
- 12 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT06314503 - No phaseTaking peopleExercise Activity to Improve Mobility in Patients With CKD and PAD
- Where
- Ferrara, Peschiera del Garda, Reggio Calabria
- Age
- 18 years to 80 years
- People
- 124
- Run by
- University Hospital of Ferrara
See details and how to joinNCT06621264 - No phaseTaking peopleRandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)
- Where
- Bari
- Age
- 18 years and over
- People
- 190
- Run by
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
See details and how to joinNCT04360694